The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A - Lusher, J M; Lee, C A; Kessler, C M; Bedrosian, C L (Haemophilia, 2003)
; ReFacto Phase 3 Study Group.